Oura agreed on November 10, 2026 to buy Counsel Health for $625 million in cash.[1] Counsel combines medical artificial intelligence (AI) with physicians who provide care through chat.[2] Oura members already had access through a partnership announced earlier this year.[3] The acquisition raises a more consequential question: what does owning Counsel give Oura that the partnership could not?
Counsel began in late 2023, making it approximately three years old at the announcement.[4] It had disclosed $36 million in venture funding.[5] Its appeal extends beyond connecting ring owners to a doctor. Counsel also brings an enterprise business and software designed to help physicians manage care across a large patient population.[1][4]
What Counsel Health Does
Counsel provides medical guidance and physician visits through text conversations. Patients can use its consumer app or access it through partners, including Oura.[3][6]
The service combines three parts:
Medical AI. You describe your concern, and the system draws on your connected records and earlier conversations to guide the exchange.[1]
Physician care. You can add a board-certified physician to the chat for diagnosis, prescriptions, or referrals when appropriate.[1]
Software for the doctor. Counsel calls its internal interface the Clinician Cockpit. It brings together patient information and suggestions for the physician to review.[1]
Through its consumer service, the AI chat is free, a physician visit costs $29, and Counsel Signature costs $300 annually for unlimited physician access. Counsel reported consumer availability in 44 states in October 2026.[6] Those prices describe access to care; readers should check medication, testing, and other charges separately before enrolling.
Counsel also sells through employers, health plans, health systems, and consumer brands. Its July launch of Counsel Studio lets partners embed the service under their own brands.[7] Counsel says its partnerships make the service available to more than eight million Americans.[2] That measures potential reach, rather than establishing how many people actively use or pay for care.
Who Built Counsel Health
Muthu Alagappan, MD founded Counsel in late 2023 and serves as chief executive.[4] An AI researcher before becoming a physician, he earned his bachelor's and medical degrees at Stanford. He later worked as an attending physician at Massachusetts General Hospital and the University of California, San Francisco, and as chief medical officer of health care automation company Notable Health.[2]
Alagappan describes Counsel's starting problem as a mismatch between demand for medical care and physician availability. The company built messaging-based care around AI and an in-house medical group.[4]
Its development followed a short timeline:
October 2024: Counsel raised an $11 million seed round for national expansion.[8]
October 2025: It raised a $25 million Series A co-led by Andreessen Horowitz and GV, formerly Google Ventures.[4]
June 2026: Counsel published its announcement of the Oura partnership.[3]
July 2026: Counsel launched its service for partners' own apps through Counsel Studio.[7]
September 2026: It announced plans to participate in a Medicare chronic-care program with Oura as its preferred wearable partner.[9]
October 2026: It launched a weight-management program, also available through LillyDirect.[6]
The path matters to the acquisition: Counsel had developed consumer access, enterprise distribution, and plans for Medicare-funded care before Oura agreed to buy it.
Alagappan will become Oura's chief clinical AI officer, with Counsel's 70 employees joining Oura, according to Bloomberg reporting cited by TechCrunch.[10]
Oura's Business Behind the Deal
Oura sells smart rings and memberships that help people track their health. Founded in Finland in 2013 and led by chief executive Tom Hale, it reported more than six million members alongside the acquisition announcement.[1]
The company reported fiscal 2026 revenue of approximately $1.75 billion, up 92%. In the quarter ended September 30, revenue reached $533 million and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) reached $87 million, a 16% margin. Those results are preliminary and unaudited.[1]
Oura also raised more than $900 million in October 2025 at an approximately $11 billion valuation.[11] That fundraising and its positive adjusted earnings provide financial context for the cash offer. They do not establish its current cash balance: adjusted EBITDA excludes some expenses and does not measure cash flow, while the company may have spent part of the funding since the round.
The purchase price equals approximately 36% of Oura's fiscal 2026 revenue, by NextMD's calculation. Oura committed to the acquisition after postponing its planned initial public offering on September 29, citing market uncertainty.[12] Our earlier coverage explains Oura's IPO plans and its expansion into physician access.
Why Buy Counsel Instead of Keeping the Partnership?
Oura's executive chairman, David Shuman, described two objectives: increasing the value of each member relationship and reaching customers through Counsel's enterprise partners.[1]
An early result helps explain the appeal. Oura launched Counsel inside Oura Labs, its hub for testing features. In September, chief medical officer Ricky Bloomfield told Fierce Healthcare that 15% of Oura Labs testers who received a Symptom Radar alert chose to connect to care through Counsel.[9] That shows a device notification prompting some users to seek care. The report does not establish how many completed a physician visit, paid for treatment, or achieved a better health outcome. The tester cohort also limits what Oura can infer about its broader membership.
Ownership could help Oura develop that connection into a larger business in three ways. These are potential benefits that still depend on execution.
1. Greater control over product development
The partnership already connects ring data with medical care.[3] Ownership could let Oura coordinate the teams developing its app, Counsel's AI, and the physician software under one business plan. That could make it easier to prioritize features spanning all three products.
A partnership requires agreement between separate businesses about what to build and fund. An acquisition can bring those decisions together, while also making the buyer responsible for the costs and execution. The companies have not disclosed enough about their earlier contract to quantify that difference.
2. A business that reaches beyond ring owners
Counsel says enterprise partners can continue working with it without purchasing Oura Rings.[2] That makes its employer and health-plan relationships relevant even when the patient has no interest in wearable hardware.
Owning Counsel could give Oura a larger economic interest in that care business. The amount depends on contract terms, customer retention, and care delivery costs. The announcements do not disclose the partnership's existing revenue-sharing terms, so the incremental benefit remains unknown.
3. An existing clinical operation
Counsel brings an in-house medical group and software built around its physicians' work. In 2025, it said the group held licenses across all 50 states.[4] That licensing footprint differs from the 44-state availability Counsel reported for its consumer service in October 2026.[6]
Acquiring those capabilities could shorten Oura's development work compared with building them internally. Owning the business also means absorbing the expense of staffing, maintaining the software, and supporting clinical quality.
Medicare and weight management add opportunities
Counsel plans to offer chronic care management at no cost to eligible Medicare beneficiaries beginning in early 2027, with Oura as its preferred wearable partner.[9] It intends to participate in the Centers for Medicare & Medicaid Services (CMS) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. CMS designed the 10-year model around payments tied to health outcomes and set its start date at July 5, 2026.[13] Counsel's planned entry is a separate date.
The opportunity is to combine ongoing medical care with additional information about a patient's daily health. Oura's sleep, activity, and cardiovascular signals can provide context. Its Health Radar does not diagnose or monitor medical conditions; those signals should not be presented as direct measurements of blood pressure or body weight.[14]
Counsel also launched a weight-management program through its own service and LillyDirect in October. Its physicians can prescribe medications such as Wegovy, Zepbound, and Foundayo when appropriate, with ongoing support.[6] Both initiatives predate the acquisition. They help explain the business Oura wants to own, but neither announcement establishes future revenue or profit.
What Counsel's Numbers Establish
Bloomfield also reported that 36,000 members completed Counsel onboarding in the first nine weeks.[9] Read that figure in the context of the Oura Labs launch. It counts onboarding, without establishing how many people completed visits or became repeat patients. Repeat use, paid conversion, and retention would show whether early interest becomes a durable business.
Counsel also reports an average physician response time of two minutes and a net promoter score of 80, a measure of customers' willingness to recommend the service.[2] Those figures describe access and satisfaction. They do not establish diagnostic accuracy or long-term health outcomes.
Three other claims need context:
96% of concerns addressed without escalation. Counsel reports this result, but its acquisition letter does not define escalation or describe follow-up for patients who later sought care elsewhere.[2]
More than 25,000 patients per physician. Counsel attributes this capacity to its software.[4] Interpreting it requires knowing how many patients actively seek care, how often they contact a physician, and what supporting staff do. It cannot serve as a direct comparison with an office-based doctor's patient panel without those details.
$381 in annual savings per engaged member. Counsel reported this in its 2025 funding account.[4] The account does not provide enough methodological detail to assess the comparison group or how much of the savings Counsel caused.
These measures justify further investigation. They leave open whether the model consistently delivers effective care at a cost that supports its pricing.
Looking at the $625 Million price
The announcements do not disclose Counsel's revenue, so they do not support a revenue multiple or a firm judgment about the price.[1][2]
The useful financial questions concern the business Oura is acquiring:
How much recurring revenue comes from enterprise contracts and consumer memberships?
How many eligible members become paying or active patients, and how long do they stay?
What does each episode of care cost after physician time and support expenses?
Can the service grow without degrading response times or clinical quality?
Oura could also benefit if physician access helps retain ring subscribers. Demonstrating that would require retention data comparing otherwise similar members with and without the service. Until the companies disclose more, the strategic rationale is easier to assess than the purchase price.
What Changes for Patients Now?
The companies expect the transaction to close before the end of 2026, subject to customary conditions and purchase price adjustments.[1] As of November 11, the acquisition announcement does not establish that the deal has closed.
Existing Oura users already have access to Counsel through the partnership. Counsel says its own application remains available for current uses for now.[2][3] The announcements do not specify a new combined membership price or a timetable for every planned service change. Patients should check their current access and fees rather than assume the acquisition makes physician care free.
Continuity can mean access to the same records, an ongoing clinical team, or the same individual physician. Counsel says it preserves earlier conversations, medical records, and other clinical context.[4] That supports continuity of information across encounters. Patients should ask who oversees follow-up and whether they can consistently see the same physician; the announcements do not establish those arrangements.
For someone comparing Counsel with concierge or direct primary care memberships, the useful questions concern access to one physician, in-person examinations, and coordination with other clinicians. A chat visit cannot provide a hands-on examination. Whether the service fits a patient's needs depends on the care required and the other clinicians involved.
Sharing Oura data with Counsel is optional.[3] Patients should also check how visit notes and prescriptions reach their regular clinician. Our guide to wearable data in the medical chart examines that coordination problem.
For concierge and direct primary care practices, a practical response is to ask which outside services patients use and establish how to review their notes, prescriptions, and relevant device data. That supports coordination while keeping responsibility for follow-up clear.
What Would Make the Acquisition Work?
The results to watch are repeat use, enterprise renewals, physician workload, clinical outcomes, and the cost of delivering care. Counsel's planned ACCESS participation could provide additional evidence about chronic-care performance, depending on the results eventually reported.[9][13]
Oura is paying to bring a care business under its ownership. The acquisition's success will depend on turning existing access and early interest into sustained patient use, effective treatment, and revenue that covers the cost of providing it.
Written by Josh Bobrowsky, founder and CEO of NextMD. This article is general information and is not medical advice.
Sources
Oura. (2026, November 10). Oura to Acquire Counsel Health, Advancing Vision for More Connected, Personalized Healthcare. Counsel Health newsroom. Read the Oura acquisition announcement
Alagappan, M. (2026, November 10). Reimagining the future of primary care alongside ŌURA. Counsel Health. Read Counsel's acquisition letter
Alagappan, M. (2026, June 3). Introducing a new era of care: Our partnership with ŌURA. Counsel Health. Read the partnership announcement
Alagappan, M. (2025, October 23). How we got here: The story behind Counsel's Series A. Counsel Health. Read Counsel's Series A letter
Aguilar, M. (2026, November 10). Oura to acquire Counsel Health for $625 million, placing a big bet on AI care. STAT. Read the STAT report
Counsel Health. (2026, October 27). Counsel Health launches weight management program, bringing continuous physician-led, AI-native care to GLP-1 treatment. Read the weight-management program announcement
Counsel Health. (2026, July 28). Counsel Health Launches Counsel Studio, Bringing AI-Enabled, Physician-Supervised Care Directly Into Healthcare Organizations' Digital Experiences. Business Wire. Read the Counsel Studio announcement
Weitzman, A. (2024, October 21). Exclusive: Counsel Health seeds $11M for national expansion. Axios Pro. Read the seed round report
Landi, H. (2026, September 17). Oura, Counsel Health join CMS ACCESS model to test whether wearables and AI can improve chronic care at scale. Fierce Healthcare. Read the ACCESS model report
Malik, A. (2026, November 10). Oura to acquire AI-native primary care startup Counsel Health for $625M. TechCrunch. Read the acquisition and leadership report
Oura. (2025, October 14). ŌURA Raises Over $900M to Accelerate Global Expansion and Health Innovation. Business Wire via Yahoo Finance. Read Oura's funding announcement
Oura. (2026, September 29). Oura Postpones Initial Public Offering. Business Wire. Read the IPO postponement announcement
Centers for Medicare & Medicaid Services. ACCESS Technical Frequently Asked Questions. Read CMS's ACCESS model FAQ
Oura. (2026, October 29). Health Radar. Oura Member Care. Read how Health Radar works and its limitations